Epstein Secrets

640.90 24,640.90 Market Value with Accruals $3,320,353.88 $3,320,353.88 J.P.Morgan SB1062192-F1 Page 2 of 29 5177 EFTA01667049 1 to idas, GIIISLAINE NIAXWEI.I, ACCT. For the Period 9/I/I I to 9/30/I I Account Summary CONTINUED Tax Summary Current Period Value Year-to-Date Value Current

n date. Interest may not be paid on any proceeds pending distribution. These restrictions apply even if the investors account at JPMorgan is closed. The Confidential Private Placement Memorandum and applicable Supplements contain other important information about the Global Access Portfolios and are available upon request. 4. Alternative as

10.393.580 (10.393.58) (9,582.88) Total Inflows & Outflows (818,381.87) 542.06 J.P. Morgan Page 73 of 77 SB1062192-F1 5396 EFTA01667268 GIIISLAINE MAXWEI.I. ACCT. For the Period 12/I/I Ito 12/31/11 TRADE ACTIVITY - Swiss Franc Note: S indicates Short Term Realized Gain'Loss • Settled trans

ate. Interest might not be paid on any proceeds pending distribution. These restrictions apply even if the investor's account at JPMorgan is closed. The Confidential Private Placement Memorandum and applicable Supplements contain other important information about the Global Access Portfolios and are available upon request or for your Investm

797.78 Market Value with Accruals $4,361,777.16 $4,361,777.16 JP Morgan Cash Filed Incomo Page 2 of 29 SB1062192-F1 6001 EFTA01667873 is GIIISLAINE NIAXWEI.I. ACCT. For the Period 2/1/13 to 2128/13 Account Summary CONTINUED Tax Suntznary Current Period Value Year-to-Date Value Current P

date. Interest might not be paid on any proceeds pending distribution. These restrictions apply even if the investors account at JPMorgan is dosed. The Confidential Private Placement Memorandum and applicable Supplements contain other important information about the Global Access Portfolios and are available upon request or for your Investm